WATER INDUSTRY FEATURES, INSIGHTS, AND ANALYSIS
-
The Devastating Legacy Of Algaecides: Why The Quick Fix Is Failing Our Lakes As warmer months approach, water management professionals must confront the compounding consequences of biocidal algae treatments.
-
What Is The Future Of Source Water Protection? Water utility managers and municipal leaders have long struggled amid the convergence of several threats to public water supplies. During a recent Water Online Live event, I sat with a panel of industry experts to examine the transition from reactive crisis management to a proactive, adaptive resilience framework.
-
Drinking Water Contaminated With 'Forever Chemicals' During Pregnancy Linked To An Increased Risk Of Childhood Asthma
While most of us are routinely exposed to low levels of PFAS, some communities are exposed to far higher levels from nearby pollution sources. A new study shows that in one of these at-risk communities, children were more likely to develop asthma if their mothers were exposed to very high PFAS levels during pregnancy.
-
The Pragmatic Shift In Source Water Protection: Moving From Symptom Management To Root-Cause Accountability A shift in how we approach source water protection is long overdue. Currently, we are trapped in a cycle of escalating costs, forced to treat symptoms like algae and invasive weeds expediently with chemicals while the underlying risk in the reservoir compounds. True risk management requires breaking this cycle.
-
The AWWA Said $2.4 Trillion. It Missed The Compound Interest. Einstein once said of compound interest, "He who understands it, earns it. He who doesn't, pays it." The same logic of compounding applies to the organic sediment accumulating on the floor of your drinking water reservoir. The longer you wait to address it, the more exponentially expensive it becomes to fix.
-
Designing Resilient PFAS Treatment Strategies For Water Agencies Water agencies across the U.S. are facing a rapidly evolving regulatory landscape for per- and polyfluoroalkyl substances (PFAS) that poses a conundrum: Should they take a cautious or aggressive approach to treating PFAS contamination in their water system?
-
The Future Of In Situ Chemical Oxidation For Targeted Solvent Destruction
The U.S. EPA’s 2026 trichloroethylene (TCE) compliance deadlines are now forcing a concrete shift toward source-zone destruction. In situ chemical oxidation (ISCO), sequenced with enhanced bioremediation, is proving to be the most credible path to groundwater contaminant rebound mitigation.
-
When Drinking Water Raises Bigger Questions About Brain Health And Environmental Risk
A new study linking certain groundwater sources to higher Parkinson’s risk underscores a broader question for the water sector: how environmental exposures in drinking water may influence long-term health.
-
EPA Seeks Court‑Ordered Removal Of 4 PFAS Limits The U.S. EPA is testing a new procedural strategy to remove four PFAS drinking‑water limits from ongoing litigation, asking the D.C. Circuit Court of Appeals to invalidate those limits on the grounds that the EPA itself committed a procedural misstep when issuing the 2024 PFAS rule.
-
Putting The National Toxicology Program's Fluoride Review In Context Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
VIEWS ON THE LATEST REGS
-
Despite renewed public concern over fluoride and cognition, the National Toxicology Program’s findings focus on high‑fluoride groundwater conditions — not the controlled levels used in U.S. drinking water systems. Understanding that distinction is critical for utilities navigating policy questions and community expectations.
-
In this Q&A, Dr. Elke Süss of Metrohm addresses the urgent need for haloacetic acid testing in response to “one of the most significant updates to EU drinking water monitoring in recent years.”
-
With the U.S. EPA's PFAS rules now in place, utilities are finding themselves with a growing number of questions regarding how to treat these chemicals, the potential costs, and much more. For answers, Water Online's chief editor, Kevin Westerling, hosted an Ask Me Anything session featuring Ken Sansone, Senior Partner at SL Environmental Law Group; Kyle Thompson, National PFAS Lead at Carollo Engineers; and Lauren Weinrich, Principal Scientist at American Water.
-
A Q&A to explain and resolve issues confronting water suppliers as they endeavor to comply with the monitoring requirements of federal PFAS regulations.
-
Assessing what lies ahead in the 10-year race to go lead-free, otherwise known as the Lead and Copper Rule Improvements (LCRI).
MORE WATER INDUSTRY FEATURES
-
Explore strategies to maximize drug product recovery during sterile filtration, minimize hold-up volume, and reduce dilution after PUPSIT to ensure higher yield, improved efficiency, and less waste.
-
Explore how Fc engineering transforms antibodies into precise therapeutic tools by modulating immune effector functions and extending half-life to improve patient outcomes and overcome complex clinical challenges.
-
Learn why piloting PFAS treatment is essential to reduce risk, optimize costs, and ensure compliance—plus the seven key steps to design a pilot that delivers reliable, real-world results.
-
Amid scrutiny of the financial conflicts of interest in biomedical research, new federal rules aim to improve transparency and preserve the integrity of publicly funded research.
-
Learn why GAC alone may fall short in PFAS treatment — and how utilities can future-proof performance with multi-barrier strategies that tackle short-chain compounds, regulatory shifts, and rising operational risks.
-
Next-generation chlorine sensors eliminate the need for reagents and membranes, while offering flow-independent, multi-parameter, self-cleaning operation. This reduces maintenance and enhances monitoring accuracy.
-
What separates genuine exosomes from microvesicles, apoptotic bodies, or lipoproteins? Explore the markers, assays, and biogenesis pathways that define these particles beyond popular terminology.
-
Flat-rate clinical trial payments are often taxable in the U.S., while reimbursements are not. Unclear tax rules can impact participant trust, site communication, and trial retention.
-
With the LCRR deadline fast approaching and over 59% of its service lines unverified, Martin County recognized the significant work ahead in preparing to meet the LCRR requirements. The county needed to establish a clear strategy for its compliance program, and to support this effort, it needed an engineering consulting partner with extensive expertise in LCRR.
-
Scalable lentiviral vector production is moving beyond adherent systems. Learn how streamlined workflows enable linear scale-up in stirred-tank bioreactors for cost-effective gene therapy manufacturing.
-
Understanding covalent warhead kinetics is key to reducing safety risks early in discovery. Learn about a new approach to GSH‑based measurements that offers clearer predictors of toxicity.
-
Whether it’s a hurricane, flood, fire, or extended power outage, the systems that sustain communities are often the first to be tested. And among all treatment technologies available, membrane bioreactors (MBRs) have proven uniquely resilient, helping utilities recover faster, maintain compliance longer, and protect the environment when stress is highest.
-
Accurate dechlorination control requires monitoring all residual oxidants that threaten membrane integrity. Total chlorine analysis provides the necessary precision at ultra-low levels, ensuring comprehensive protection against oxidative damage while maintaining reagent stability during intermittent system operations.
-
What's really at stake when choosing between surface water and groundwater? The answer shapes water security for decades.
-
This article isn’t about the theoretical benefits of MBR technology. It’s about what actually impacts day-to-day MBR operation—and what makes an MBR plant feel intuitive, stable, and predictable… or frustratingly complex.
-
Explore how PFAS in medical devices pose environmental and health concerns, prompting regulatory scrutiny.
-
Anshul Gupte Ph.D., shares insight about phase-appropriate development, technical hurdles, building agile teams, and planning strategy for novel therapies.
-
Legacy oilfield contamination requires advanced strategies to protect vital groundwater. Explore the technical challenges of subsurface remediation and how advanced oxidation processes provide a more effective pathway for destroying persistent hydrocarbons and restoring aquifer quality.